Human innate immune cell crosstalk induces melanoma cell senescence.
NK cell
cytokines
melanoma
senescence
slanMo
Journal
Oncoimmunology
ISSN: 2162-4011
Titre abrégé: Oncoimmunology
Pays: United States
ID NLM: 101570526
Informations de publication
Date de publication:
30 08 2020
30 08 2020
Historique:
entrez:
17
9
2020
pubmed:
18
9
2020
medline:
18
9
2020
Statut:
epublish
Résumé
Mononuclear phagocytes and NK cells constitute the first line of innate immune defense. How these cells interact and join forces against cancer is incompletely understood. Here, we observed an early accumulation of slan
Identifiants
pubmed: 32939325
doi: 10.1080/2162402X.2020.1808424
pii: 1808424
pmc: PMC7470184
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
1808424Informations de copyright
© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.
Références
Cell Death Discov. 2017 Aug 21;3:17049
pubmed: 28845296
Nat Commun. 2014;5:3029
pubmed: 24398631
Aging (Albany NY). 2017 Nov 22;9(11):2411-2435
pubmed: 29176033
J Immunol Res. 2015;2015:839684
pubmed: 26543875
Oncotarget. 2015 May 30;6(15):13835-43
pubmed: 26079948
J Immunol. 2020 Jan 1;204(1):192-198
pubmed: 31767784
Cell. 2002 May 3;109(3):335-46
pubmed: 12015983
Nature. 2007 Feb 8;445(7128):656-60
pubmed: 17251933
Nature. 2013 Feb 21;494(7437):361-5
pubmed: 23376950
Mol Cancer. 2007 Jun 12;6:42
pubmed: 17565690
Science. 2015 Nov 20;350(6263):985-90
pubmed: 26494174
Dermatol Surg. 2012 Jun;38(6):937-46
pubmed: 22338583
Cancer Res. 2018 Jul 1;78(13):3544-3559
pubmed: 29748373
Clin Cancer Res. 2016 Aug 1;22(15):3924-36
pubmed: 26957562
Annu Rev Pathol. 2010;5:99-118
pubmed: 20078217
Cancer Res. 2011 Sep 15;71(18):5998-6009
pubmed: 21764762
Cell. 2018 Jan 25;172(3):534-548.e19
pubmed: 29275861
Int J Cancer. 2009 Jan 15;124(2):358-66
pubmed: 18942710
Immunity. 2006 Jun;24(6):767-77
pubmed: 16782032
Cell. 1997 Mar 7;88(5):593-602
pubmed: 9054499
J Am Acad Dermatol. 2000 Sep;43(3):555-6
pubmed: 10954675
Oncoimmunology. 2012 Jul 1;1(4):448-457
pubmed: 22754763
J Immunol. 2009 Sep 1;183(5):3425-32
pubmed: 19667085
Cell Mol Immunol. 2017 Dec;14(12):976-985
pubmed: 27086951
J Immunol. 2005 Apr 1;174(7):4127-34
pubmed: 15778372
Cancer Metastasis Rev. 2017 Jun;36(2):357-365
pubmed: 28391403
PLoS One. 2014 Mar 28;9(3):e93232
pubmed: 24681574
Ochsner J. 2015 Winter;15(4):443-7
pubmed: 26730231
Clin Cancer Res. 2019 May 1;25(9):2887-2899
pubmed: 30705034
Cancer Cell. 2016 Oct 10;30(4):533-547
pubmed: 27728804
Nature. 2018 Jan 4;553(7686):96-100
pubmed: 29258294
Front Immunol. 2018 Oct 11;9:2324
pubmed: 30364222
Cancer Res. 2013 Jan 1;73(1):450-8
pubmed: 23288917
Eur J Immunol. 1998 Dec;28(12):4084-93
pubmed: 9862344
Cancer Res. 2007 Apr 1;67(7):3117-26
pubmed: 17409418
Science. 1998 Nov 20;282(5393):1497-501
pubmed: 9822382
Immunity. 2002 Sep;17(3):289-301
pubmed: 12354382
Oncogene. 1998 Jan 22;16(3):311-20
pubmed: 9467956
Acta Derm Venereol. 2019 Sep 1;99(10):884-888
pubmed: 31233181
Immunity. 2010 Sep 24;33(3):375-86
pubmed: 20832340
J Biol Chem. 1998 Sep 11;273(37):23830-6
pubmed: 9726994
Aging (Albany NY). 2016 Feb;8(2):328-44
pubmed: 26878797
Oncotarget. 2016 Jan 5;7(1):161-75
pubmed: 26695549
J Immunol. 2015 Aug 1;195(3):1162-70
pubmed: 26085686
Nat Commun. 2017 May 10;8:15208
pubmed: 28489070
Sci Transl Med. 2014 May 21;6(237):237ra67
pubmed: 24848257
J Exp Med. 2013 Sep 23;210(10):2057-69
pubmed: 24043758
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7
pubmed: 7568133
Nat Commun. 2017 Mar 20;8:14728
pubmed: 28317845
Cell. 2013 Apr 11;153(2):449-60
pubmed: 23562644
J Immunol. 2014 Apr 15;192(8):3805-15
pubmed: 24646734
Blood. 2002 Aug 15;100(4):1502-4
pubmed: 12149240
Cell. 2018 Feb 22;172(5):1022-1037.e14
pubmed: 29429633
Cancer Res. 1997 Nov 1;57(21):4868-75
pubmed: 9354451
Nat Cell Biol. 2013 Aug;15(8):978-90
pubmed: 23770676
Immunol Lett. 2014 Oct;161(2):168-73
pubmed: 24361820